Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Optina Diagnostics develops technology for the early detection of disease through the eye.
Rinri Therapeutics is a biotechnology company developing a novel cell-based therapy.
Delonix Bioworks is working on synthetic biology approaches to develop the next generation medical solutions for infectious diseases.
Libra Therapeutics is a biotechnology company.
Predicting worsening fluid status in a single step.
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
Metabomed designs drugs that treats cancer.
Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.
Aelin Therapeutics is a provider of a biotherapeutics platform technology called pept-ins that are intended to harnesses.
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.
STAT-Dx is focused on the development of near-patient testing products for healthcare professionals.
ViraTherapeutics develops highly potent anti-cancer therapeutics based on oncolytic viruses.
Boehringer Ingelheim Venture Fund has invested in 60 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Boehringer Ingelheim Venture Fund's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Oncology. The firm invests across 11 different industry categories.
Among tracked funding rounds, Amal Therapeutics received $32.6M in a Series B round. Boehringer Ingelheim Venture Fund's total known invested capital is $836.9M.
Boehringer Ingelheim Venture Fund's average investment size is $17.4M across its portfolio of 60 companies.
Recent Boehringer Ingelheim Venture Fund portfolio additions include Optina Diagnostics, Rinri Therapeutics, Delonix Bioworks, Libra Therapeutics, Bodyport. These companies were founded in 2020 or later.